Apart from that, TAMs (tumor-associated macrophages) and Aurora-A inhibition also played the key role in regulating the activity of anti-PD-1/PD-L1 agents for breast cancer (Santoni et al., 2018; Yin et al., 2019). This evidence concerns the gene CD274 and breast cancer.